1. Петрова Н.В. Диагностика имплант-ассоциированных инфекций в ортопедии с позиции доказательной медицины. Хирургия позвоночника. 2012. (1). 74–83.
2. Berbari E., Mabry T., Tsaras G., Spangehl M. et al. Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J. Bone Joint Surg. Am. 2010. 92. (11). S2102–S2109.
3. Buttaro M.A., Tanoira I., Comba F., Piccaluga F. Combining C-reactive protein and interleukin-6 may be useful to detect periprosthetic hip infection. Clin. Orthop. Relat. Res. 2010. 468. (12). 3263–3267.
4. Darwiche H., Barsoum W.K., Klika A. et al. Retrospective analysis of infection rate after early reoperation in total hip arthroplasty. Clin. Orthop. Relat. Res. 2010. 468. (9). 2392–2396.
5. Di Cesare P.E., Chang E., Preston C.F. et al. Serum Interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty. J. Bone Joint Surg. Am. 2005. 87. 1921–1927.
6. Drago L., Vassena C., Dozio E. et al. Procalcitonin, C-reactive protein, interleukin-6, and soluble intercellular adhesion molecule-1 as markers of postoperative orthopaedic joint prosthesis infections. Int. J. Immunopathol. Pharmacol. 2011. 24. (2). 433–440.
7. Elgeidi A., Elganainy A.E., Abou Elkhier N., Rakha S. Interleukin-6 and other inflammatory markers in diagnosis of periprosthetic joint infection. Int. Orthop. 2014. 38. (12). 2591–2595.
8. Finn A., Angeby Möller K., Gustafsson C., Abdelmoaty S. et al. Influence of model and matrix on cytokine profile in rat and human Rheumatology (Oxford). 2014. 53. (12). 2297–2305.
9. Hoell S., Borgers L., Gosheger G. et al. Interleukin-6 in two-stage revision arthroplasty: what is the threshold value to exclude persistent infection before re-implanatation?. Bone Joint J. 2015. 97-B. (1). 71–75.
10. Jacovides C.L., Parvizi J., Adeli B., Jung K.A. Molecular markers for diagnosis of periprosthetic joint infection. J. Arthroplasty. 2011. 26. (6). 99–103.
11. Papanicolaou D.A., Wilder R.L., Manolagas S.C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 1998. 128. (2). 127–137.
12. Randau T.M., Friedrich M.J., Wimmer M.D. et al. Interleukin-6 in serum and in synovial fluid enhances the differentiation between periprosthetic joint infection and aseptic loosening. PLoS One. 2014. 9. (2). ID 89045.
13. Shah K., Mohammed A., Patil S. et al. Circulating cytokines after hip and knee arthroplasty: a preliminary study. Clin. Orthop. Relat. Res. 2009. 467. (4). 946–951.
14. Springer B.D., Scuderi G.R. Evaluation and management of the infected total knee arthroplasty. Instr. Course Lect. 2013. 62. 349–361.
15. Wirtz D.C., Heller K.D., Miltner O. et al. Interleukin-6: a potential inflammatory marker after total joint replacement. Int. Orthop. 2000. 24. 194–196.
16. Yoshitake F., Itoh S., Narita H. et al. Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways. J. Biol. Chem. 2008. 283. (17). 11535–11540.
Об авторах (для корреспонденции):
Чепелева М.В. – к.м.н., старший научный сотрудник научно-клинической лаборатории микробиологии и иммунологии, e-mail: Vladi_2000@hotbox.ru
Клюшин Н.М. – д.м.н., зав. лабораторией гнойной остеологии, e-mail: elenka@mail.ru
Ермаков А.М. – врач-травматолог-ортопед отделения гнойной остеологии № 1
Абабков Ю.В. – врач-травматолог-ортопед, зав отделением гнойной остеологии № 1